SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
- Address
- Viale San Luca 5, Florence, Italy
SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
The SOD Centro Cefalee e Farmacologia Clinica at AOU Careggi is a specialized center dedicated to headache disorders and clinical pharmacology research. With expertise in complex migraine management, the center focuses on evaluating novel therapeutic approaches for patients who have experienced inadequate responses to conventional treatments.
- Migraine prevention trials using innovative dosing regimens and next-generation therapies
- Evaluation of treatment efficacy in difficult-to-treat patient populations with prior therapeutic failures
- Clinical pharmacology studies examining tolerability and safety profiles of emerging headache medications
The center specializes in migraine headaches with or without aura, conducting rigorous placebo-controlled trials to establish efficacy endpoints. Their research methodology includes comprehensive observation phases and double-blind treatment protocols, measuring critical outcomes such as mean reduction in migraine days per month. This systematic approach positions the center at the forefront of developing evidence-based preventive strategies for patients with inadequate response to oral preventive medications.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SOD Centro Cefalee e Farmacologia Clinica, AOU Careggi
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase 4 Randomized Double-Blind Placebo-Controlled Study on Rimegepant Efficacy and Tolerability in Migraine Prophylaxis for Adults with Inadequate Oral Preventive Response | Pfizer Inc. | Phase III | Not Recruiting | Mar 2023 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rimegepant | 1 | Unknown | 2023-03-14 | 2023-03-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.